Symbols / BCDA $1.18 -1.67% BioCardia, Inc.

Healthcare • Biotechnology • United States • NCM
BCDA Chart
About

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. The company's lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. It also provides CardiALLO, an allogeneic mesenchymal stem cell therapy which is in phase II for ischemic heart failure; allogeneic cell therapy platform; and PulmALLO, an allogeneic mesenchymal stem cell therapy for acute respiratory distress syndrome. In addition, the company offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; Heart3D for fusion imaging; and morph DNA and avance steerable introducers. It has a license and distribution agreement with Biomet Biologics, LLC. BioCardia, Inc. is based in Sunnyvale, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 12.91M
Enterprise Value 11.16M Income -8.23M Sales —
Book/sh 0.08 Cash/sh 0.23 Dividend Yield —
Payout 0.00% Employees 17 IPO —
P/E — Forward P/E -2.11 PEG —
P/S — P/B 14.22 P/C —
EV/EBITDA -1.35 EV/Sales — Quick Ratio 1.03
Current Ratio 1.12 Debt/Eq 58.99 LT Debt/Eq —
EPS (ttm) -1.23 EPS next Y -0.56 EPS Growth —
Revenue Growth — Earnings 2026-03-24 16:00 ROA -144.98%
ROE -9.50% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 10.94M
Shs Float 8.34M Short Float 2.14% Short Ratio 3.64
Short Interest — 52W High 3.20 52W Low 1.00
Beta 0.55 Avg Volume 68.67K Volume 27.91K
Target Price $15.50 Recom Strong_buy Prev Close $1.20
Price $1.18 Change -1.67%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$15.50
Mean price target
2. Current target
$1.18
Latest analyst target
3. DCF / Fair value
$-7.66
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.18
Low
$6.00
High
$25.00
Mean
$15.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-09-22 reit HC Wainwright & Co. Buy → Buy $25
2024-12-18 reit HC Wainwright & Co. Buy → Buy $25
2024-11-14 reit HC Wainwright & Co. Buy → Buy $25
2024-10-28 reit HC Wainwright & Co. Buy → Buy $25
2024-08-21 reit HC Wainwright & Co. Buy → Buy $25
2024-08-16 main HC Wainwright & Co. Buy → Buy $25
2024-07-26 reit HC Wainwright & Co. Buy → Buy $4
2024-05-29 reit HC Wainwright & Co. Buy → Buy $4
2023-11-14 reit HC Wainwright & Co. Buy → Buy $4
2023-10-11 reit HC Wainwright & Co. Buy → Buy $4
2023-09-06 main HC Wainwright & Co. Buy → Buy $4
2023-08-10 reit HC Wainwright & Co. Buy → Buy $9
2023-07-24 reit HC Wainwright & Co. Buy → Buy $9
2023-06-21 reit HC Wainwright & Co. Buy → Buy $9
2023-05-11 reit HC Wainwright & Co. Buy → Buy $9
2023-03-30 reit HC Wainwright & Co. — → Buy $9
2022-11-11 down Dawson James Buy → Neutral —
2021-12-20 init HC Wainwright & Co. — → Buy $9
2021-04-16 down Dawson James Buy → Neutral —
2020-09-21 init Alliance Global Partners — → Buy $12
News
RSS: Latest BCDA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-25 ALTMAN PETER Chief Executive Officer — 900 $1.22 $1,110
2026-02-04 ALTMAN PETER Chief Executive Officer — 5,000 $1.13 $5,650
2026-01-21 ALTMAN PETER Chief Executive Officer — 900 $1.32 $1,194
2025-12-17 ALTMAN PETER Chief Executive Officer — 1,100 $1.30 $1,444
2025-12-08 GILLIS EDWARD M Officer — 38,078 $1.37 $52,167
2025-12-08 MCCLUNG DAVID Chief Financial Officer — 58,276 $1.37 $79,838
2025-12-08 ALTMAN PETER Chief Executive Officer — 106,588 $1.37 $146,026
2025-09-19 BLANK ANDREW SCOTT Director — 288,000 $1.25 $360,000
2025-09-19 ALTMAN PETER Chief Executive Officer — 48,000 $1.25 $60,000
2025-09-19 STERTZER SIMON H Director — 398,400 $1.25 $498,000
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
-100.00%
0.06
-87.84%
0.48
-64.72%
1.35
Operating Revenue
0.00
-100.00%
0.06
-87.84%
0.48
-64.72%
1.35
Cost Of Revenue
—
—
—
—
Reconciled Cost Of Revenue
—
—
—
—
Gross Profit
—
—
—
—
Operating Expense
8.28
+2.72%
8.06
-33.51%
12.12
-8.54%
13.25
Research And Development
4.96
+13.11%
4.39
-43.22%
7.73
-12.54%
8.83
Selling General And Administration
3.32
-9.69%
3.67
-16.45%
4.39
-0.54%
4.42
Total Expenses
8.28
+2.72%
8.06
-33.51%
12.12
-8.54%
13.25
Operating Income
-8.28
-3.46%
-8.00
+31.29%
-11.64
+2.16%
-11.90
Total Operating Income As Reported
-8.28
-3.46%
-8.00
+31.29%
-11.64
+2.16%
-11.90
EBITDA
-8.25
-4.03%
-7.93
+31.37%
-11.56
+2.19%
-11.82
Normalized EBITDA
-8.25
-4.03%
-7.93
+31.37%
-11.56
+2.19%
-11.82
Reconciled Depreciation
0.02
-64.18%
0.07
-20.24%
0.08
+2.44%
0.08
EBIT
-8.28
-3.46%
-8.00
+31.29%
-11.64
+2.16%
-11.90
Total Unusual Items
—
—
—
—
Total Unusual Items Excluding Goodwill
—
—
—
—
Special Income Charges
—
—
—
—
Net Income
-8.23
-3.55%
-7.95
+31.33%
-11.57
+2.82%
-11.91
Pretax Income
-8.23
-3.55%
-7.95
+31.33%
-11.57
+2.82%
-11.91
Net Non Operating Interest Income Expense
—
—
—
—
Interest Expense Non Operating
—
—
—
—
Net Interest Income
—
—
—
—
Interest Expense
—
—
—
—
Interest Income Non Operating
—
—
—
—
Interest Income
—
—
—
—
Other Income Expense
0.05
-9.09%
0.06
-24.66%
0.07
+1316.67%
-0.01
Other Non Operating Income Expenses
0.05
-9.09%
0.06
-24.66%
0.07
+1316.67%
-0.01
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-8.23
-3.55%
-7.95
+31.33%
-11.57
+2.82%
-11.91
Net Income From Continuing Operation Net Minority Interest
-8.23
-3.55%
-7.95
+31.33%
-11.57
+2.82%
-11.91
Net Income From Continuing And Discontinued Operation
-8.23
-3.55%
-7.95
+31.33%
-11.57
+2.82%
-11.91
Net Income Continuous Operations
-8.23
-3.55%
-7.95
+31.33%
-11.57
+2.82%
-11.91
Normalized Income
-8.23
-3.55%
-7.95
+31.33%
-11.57
+2.82%
-11.91
Net Income Common Stockholders
-8.23
-3.55%
-7.95
+31.33%
-11.57
+2.82%
-11.91
Diluted EPS
-1.23
+57.59%
-2.90
+64.59%
-8.19
+18.51%
-10.05
Basic EPS
-1.23
+57.59%
-2.90
+64.59%
-8.19
+18.51%
-10.05
Basic Average Shares
6.67
+142.98%
2.74
+94.32%
1.41
+19.52%
1.18
Diluted Average Shares
6.67
+142.98%
2.74
+94.32%
1.41
+19.52%
1.18
Diluted NI Availto Com Stockholders
-8.23
-3.55%
-7.95
+31.33%
-11.57
+2.82%
-11.91
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
3.41
-8.35%
3.72
+24.67%
2.99
-69.50%
9.79
Current Assets
2.73
+4.20%
2.62
+79.47%
1.46
-81.42%
7.86
Cash Cash Equivalents And Short Term Investments
2.50
+5.27%
2.37
+114.96%
1.10
-85.02%
7.36
Cash And Cash Equivalents
2.50
+5.27%
2.37
+114.96%
1.10
-85.02%
7.36
Cash Equivalents
—
0.00
+0.00%
0.00
-99.97%
6.89
Cash Financial
2.50
+5.36%
2.37
+115.17%
1.10
+134.26%
0.47
Receivables
0.02
0.00
-100.00%
0.06
-68.66%
0.20
Accounts Receivable
0.02
0.00
-100.00%
0.06
-68.66%
0.20
Gross Accounts Receivable
0.02
0.00
-100.00%
0.10
-54.25%
0.21
Allowance For Doubtful Accounts Receivable
0.00
0.00
+100.00%
-0.03
-209.09%
-0.01
Prepaid Assets
0.22
-13.94%
0.25
—
—
Other Current Assets
—
0.25
-14.92%
0.29
-1.67%
0.30
Total Non Current Assets
0.68
-38.20%
1.10
-27.83%
1.53
-20.80%
1.93
Net PPE
0.51
-45.22%
0.93
-31.34%
1.36
-22.82%
1.76
Gross PPE
1.29
-23.46%
1.69
-17.46%
2.05
-13.72%
2.38
Accumulated Depreciation
-0.79
-3.15%
-0.76
-9.65%
-0.69
-12.12%
-0.62
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
—
—
—
1.59
Machinery Furniture Equipment
0.20
+3.65%
0.19
+2.13%
0.19
+0.00%
0.19
Construction In Progress
—
—
—
0.00
Other Properties
1.07
-27.41%
1.47
-19.72%
1.84
-15.08%
2.16
Leases
0.03
+0.00%
0.03
+0.00%
0.03
+0.00%
0.03
Other Non Current Assets
0.17
+0.00%
0.17
+0.00%
0.17
+0.00%
0.17
Total Liabilities Net Minority Interest
2.52
-12.78%
2.89
-37.10%
4.59
-6.35%
4.90
Current Liabilities
2.43
+4.78%
2.32
-35.67%
3.61
+0.64%
3.58
Payables And Accrued Expenses
1.46
+3.63%
1.40
-48.27%
2.71
+17.74%
2.31
Payables
0.64
+66.49%
0.39
-59.94%
0.96
+37.09%
0.70
Accounts Payable
0.64
+66.49%
0.39
-56.74%
0.89
+30.31%
0.68
Current Accrued Expenses
0.81
-20.12%
1.02
-41.87%
1.75
+9.29%
1.60
Current Debt And Capital Lease Obligation
0.44
+14.81%
0.39
+15.62%
0.33
+5.71%
0.32
Current Capital Lease Obligation
0.44
+14.81%
0.39
+15.62%
0.33
+5.71%
0.32
Current Deferred Liabilities
0.54
+0.56%
0.53
-5.17%
0.56
-41.87%
0.96
Current Deferred Revenue
0.54
+0.56%
0.53
-5.17%
0.56
-41.87%
0.96
Total Non Current Liabilities Net Minority Interest
0.09
-84.81%
0.57
-42.36%
0.98
-25.38%
1.32
Long Term Debt And Capital Lease Obligation
0.09
-84.81%
0.57
-42.36%
0.98
-25.38%
1.32
Long Term Capital Lease Obligation
0.09
-84.81%
0.57
-42.36%
0.98
-25.38%
1.32
Stockholders Equity
0.90
+6.93%
0.84
+152.21%
-1.60
-132.77%
4.89
Common Stock Equity
0.90
+6.93%
0.84
+152.21%
-1.60
-132.77%
4.89
Capital Stock
0.01
+120.00%
0.01
+150.00%
0.00
-90.00%
0.02
Common Stock
0.01
+120.00%
0.01
+150.00%
0.00
-90.00%
0.02
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
10.61
+130.58%
4.60
+191.61%
1.58
+17.88%
1.34
Ordinary Shares Number
10.61
+130.58%
4.60
+191.61%
1.58
+17.88%
1.34
Additional Paid In Capital
169.23
+5.14%
160.95
+6.90%
150.57
+3.50%
145.48
Retained Earnings
-168.35
-5.14%
-160.12
-5.22%
-152.18
-8.23%
-140.60
Total Equity Gross Minority Interest
0.90
+6.93%
0.84
+152.21%
-1.60
-132.77%
4.89
Total Capitalization
0.90
+6.93%
0.84
+152.21%
-1.60
-132.77%
4.89
Working Capital
0.30
-0.33%
0.30
+114.02%
-2.15
-150.18%
4.28
Invested Capital
0.90
+6.93%
0.84
+152.21%
-1.60
-132.77%
4.89
Total Debt
0.53
-44.48%
0.95
-27.68%
1.31
-19.37%
1.63
Capital Lease Obligations
0.53
-44.48%
0.95
-27.68%
1.31
-19.37%
1.63
Net Tangible Assets
0.90
+6.93%
0.84
+152.21%
-1.60
-132.77%
4.89
Tangible Book Value
0.90
+6.93%
0.84
+152.21%
-1.60
-132.77%
4.89
Duefrom Related Parties Current
—
—
—
—
Dueto Related Parties Current
—
0.00
-100.00%
0.07
+294.44%
0.02
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-7.44
+5.71%
-7.89
+20.93%
-9.97
+5.56%
-10.56
Cash Flow From Continuing Operating Activities
-7.44
+5.71%
-7.89
+20.93%
-9.97
+5.56%
-10.56
Net Income From Continuing Operations
-8.23
-3.55%
-7.95
+31.33%
-11.57
+2.82%
-11.91
Depreciation Amortization Depletion
0.02
-64.18%
0.07
-20.24%
0.08
+2.44%
0.08
Depreciation
0.02
-64.18%
0.07
-20.24%
0.08
+2.44%
0.08
Depreciation And Amortization
0.02
-64.18%
0.07
-20.24%
0.08
+2.44%
0.08
Stock Based Compensation
0.43
-41.97%
0.74
-28.06%
1.03
-12.93%
1.18
Provisionand Write Offof Assets
0.00
+100.00%
-0.03
-247.83%
0.02
—
Asset Impairment Charge
—
—
—
0.29
Operating Gains Losses
0.48
-0.21%
0.48
+45.62%
0.33
+12.20%
0.29
Gain Loss On Sale Of PPE
0.48
-0.21%
0.48
+45.62%
0.33
+12.20%
0.29
Change In Working Capital
-0.14
+88.04%
-1.20
-1027.13%
0.13
+160.28%
-0.21
Change In Receivables
-0.02
-120.62%
0.10
-15.65%
0.12
+312.96%
-0.05
Changes In Account Receivables
-0.02
-120.62%
0.10
-15.65%
0.12
+312.96%
-0.05
Change In Inventory
—
—
—
—
Change In Prepaid Assets
0.04
-20.45%
0.04
+780.00%
0.01
-96.93%
0.16
Change In Payables And Accrued Expense
0.34
+140.05%
-0.85
-228.23%
0.67
+58.57%
0.42
Change In Accrued Expense
0.18
+133.27%
-0.54
-211.62%
0.48
+15.87%
0.42
Change In Payable
0.16
+151.58%
-0.32
-271.74%
0.18
+4500.00%
0.00
Change In Account Payable
0.16
+151.58%
-0.32
-271.74%
0.18
+4500.00%
0.00
Change In Other Working Capital
—
—
-0.34
+32.61%
-0.51
Change In Other Current Assets
—
—
—
—
Change In Other Current Liabilities
-0.50
-3.52%
-0.48
-52.85%
-0.32
-33.33%
-0.24
Investing Cash Flow
-0.01
-16.67%
-0.01
+50.00%
-0.01
+82.86%
-0.07
Cash Flow From Continuing Investing Activities
-0.01
-16.67%
-0.01
+50.00%
-0.01
+82.86%
-0.07
Net PPE Purchase And Sale
-0.01
-16.67%
-0.01
+50.00%
-0.01
+82.86%
-0.07
Purchase Of PPE
-0.01
-16.67%
-0.01
+50.00%
-0.01
+82.86%
-0.07
Capital Expenditure
-0.01
-16.67%
-0.01
+50.00%
-0.01
+82.86%
-0.07
Financing Cash Flow
7.57
-17.38%
9.16
+145.84%
3.73
-27.25%
5.12
Cash Flow From Continuing Financing Activities
7.57
-17.38%
9.16
+145.84%
3.73
-27.25%
5.12
Net Issuance Payments Of Debt
—
—
—
—
Issuance Of Debt
—
—
—
—
Long Term Debt Issuance
—
—
—
—
Net Long Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
8.69
-17.65%
10.55
+140.47%
4.39
-20.79%
5.54
Proceeds From Stock Option Exercised
0.01
0.00
—
0.00
Net Other Financing Charges
-1.13
+19.04%
-1.39
-110.27%
-0.66
-58.37%
-0.42
Changes In Cash
0.12
-90.14%
1.27
+120.26%
-6.26
-13.63%
-5.51
Beginning Cash Position
2.37
+114.96%
1.10
-85.02%
7.36
-42.80%
12.87
End Cash Position
2.50
+5.27%
2.37
+114.96%
1.10
-85.02%
7.36
Free Cash Flow
-7.44
+5.69%
-7.89
+20.97%
-9.99
+6.07%
-10.63
Common Stock Issuance
8.69
-17.65%
10.55
+140.47%
4.39
-20.79%
5.54
Issuance Of Capital Stock
8.69
-17.65%
10.55
+140.47%
4.39
-20.79%
5.54
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category